NCT07036159View on ClinicalTrials.gov

A Study to Assess the Safety and Immunogenicity of a Vaccine Against Malaria in Healthy Children Aged 5-60 Months

PHASE2RecruitingINTERVENTIONAL

Enrollment

238

Participants

Timeline

Start Date

August 6, 2025

Primary Completion Date

April 23, 2027

Study Completion Date

April 23, 2027

Conditions

Malaria

Interventions

BIOLOGICAL

RTS,S/AS01E vaccine

RTS,S/AS01E vaccine will be administered intramuscularly.

Trial Locations (2)

Unknown

RECRUITING

GSK Investigational Site, Kigali

RECRUITING

GSK Investigational Site, Kigali

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY